MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
4.730
-0.080 (-1.66%)
Oct 6, 2025, 4:00 PM EDT - Market closed
MDxHealth Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MDxHealth stock has a target of 6.00, which predicts a 26.85% increase from the current stock price of 4.73.
Price Target: $6.00 (+26.85%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MDxHealth is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +26.85% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +47.99% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +69.13% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +26.85% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +47.99% | May 31, 2023 |
Financial Forecast
Revenue This Year
112.02M
from 90.05M
Increased by 24.40%
Revenue Next Year
136.99M
from 112.02M
Increased by 22.29%
EPS This Year
-0.53
from -1.16
EPS Next Year
-0.28
from -0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 120.3M | 163.0M | ||
| Avg | 112.0M | 137.0M | ||
| Low | 106.3M | 122.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 33.6% | 45.5% | ||
| Avg | 24.4% | 22.3% | ||
| Low | 18.1% | 9.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.35 | -0.02 | |
| Avg | -0.53 | -0.28 | |
| Low | -0.57 | -0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.